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ABSTRACT 
The discovery of potent inhibitors of prostaglandin E2 (PGE2) synthesis in recent years has 
been proven to be an important game changer in pharmaceutical industry. It is known that 
excessive production of PGE2 triggers a vast array of biological signals and physiological 
events that contributes to inflammatory diseases such as rheumatoid arthritis, atherosclerosis, 
cancer, and pain. In this Letter, we report the synthesis of a series of minor prenylated 
chalcones and flavonoids which was found to be significantly active in suppressing the PGE2 
production secreted by lipopolysaccharide-induced mouse macrophage cells (RAW 264.7). 
Among the compounds tested, 14b showed a dose-response inhibition of PGE2 production 
with an IC50 value of 2.1 μM. The suppression upon PGE2 secretion was not due to cell 
death since 14b did not reduce the cell viability in close proximity to the PGE2 inhibition 
concentration. The obtained atomic coordinates for the single-crystal XRD of 14b was then 
applied in the docking simulation to determine the potential important binding interactions 
with murine COX-2 and mPGES-1 putative binding sites.  
Keyword: Prenylated chalcone; Minor flavonoids; Single-crystal XRD; Prostaglandin E2; 
COX-2 inhibitor; ADMET prediction 
